29. Lufkin T (1996) Transcriptional control of Hox genes in the vertebrate nervous system. Curr Opin Genet Dev 6: 575–580. 30. Sawhney N, Hall PA (1992) Ki67–structure, function, and new antibodies. J Pathol 168: 161–162. 31. Murray AW (2004) Recycling the cell cycle: cyclins revisited. Cell 116: 221–234. 32. Satyanarayana A, Kaldis P (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28: 2925–2939. 33. Gaetano C, Matsumoto K, Thiele CJ (1991) Retinoic acid negatively regulates p34cdc2 expression during human neuroblastoma differentiation. Cell Growth Differ 2: 487–493. 34. Matsuo T, Thiele CJ (1998) p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16: 3337–3343. 35. Alam G, Cui H, Shi H, Yang L, Ding J, et al. (2009) MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol 175: 856–866. 36. Hahn CK, Ross KN, Warrington IM, Mazitschek R, Kanegai CM, et al. (2008) Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. Proc Natl Acad Sci U S A 105: 9751–9756. 37. Svingen T, Tonissen KF (2006) Hox transcription factors and their elusive mammalian gene targets. Heredity 97: 88–96. 38. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G (2007) Genome regulation by polycomb and trithorax proteins. Cell 128: 735–745. 39. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiother- apy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med 341: 1165–1173. HOXD Regulation of Neuroblastoma Differentiation 40. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, et al. (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children’s oncology group study. J Clin Oncol 27: 1007–1013. 41. Marshall H, Morrison A, Studer M, Popperl H, Krumlauf R (1996) Retinoids and Hox genes. FASEB J 10: 969–978. 42. Soshnikova N, Duboule D (2009) Epigenetic temporal control of mouse Hox genes in vivo. Science 324: 1320–1323. 43. Lawrence PA, Morata G (1994) Homeobox genes: their function in Drosophila segmentation and pattern formation. Cell 78: 181–189. 44. Chisaka O, Capecchi MR (1991) Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 350: 473–479. 45. Greer JM, Puetz J, Thomas KR, Capecchi MR (2000) Maintenance of functional equivalence during paralogous Hox gene evolution. Nature 403: 661– 665. 46. Zhao Y, Potter SS (2002) Functional comparison of the Hoxa 4, Hoxa 10, and Hoxa 11 homeoboxes. Dev Biol 244: 21–36. 47. Duboule D (2007) The rise and fall of Hox gene clusters. Development 134: 2549–2560. 48. Yahagi N, Kosaki R, Ito T, Mitsuhashi T, Shimada H, et al. (2004) Position- specific expression of Hox genes along the gastrointestinal tract. Congenit Anom (Kyoto) 44: 18–26. 49. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1997) Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 124: 4065–4075. 50. Silva JM, Marran K, Parker JS, Silva J, Golding M, et al. (2008) Profiling essential genes in human mammary cells by multiplex RNAi screening. Science 319: 617–620. PLoS ONE | www.plosone.org 11 August 2012 | Volume 7 | Issue 8 | e40728